ABVC BIOPHARMA, INC. (ABVC) › Shareholders' EquityABVC BIOPHARMA, INC. (ABVC) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2010: -$2.99M2011: -$1.46M2012: -$1.64M2013: -$1.88M2014: $31.4K2015: $633.4K2016: -$6.52M2017: -$1.76M2018: -$5.66M2019: -$151.0K2020: $3.44M2021: $8.84M2022: $3.10M2023: $1.55M2024: $1.23M2025: $11.11M$11.11M2010Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$11.11M+806.2%2024$1.23M-21.1%2023$1.55M-49.8%2022$3.10M-65.0%2021$8.84M+157.2%2020$3.44M+2377.6%2019-$151.0K+97.3%2018-$5.66M-222.0%2017-$1.76M+73.1%2016-$6.52M-1129.3%2015$633.4K+1919.7%2014$31.4K+101.7%2013-$1.88M-14.4%2012-$1.64M-12.3%2011-$1.46M+51.1%2010-$2.99M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share